4
Changes in Ownership
PROCEPT BioRobotics Corp Filed Acc 0001628280-24-050221
EVP, CLO, CORP. SEC. sold 28,092 shares at an average $97.13 ($2,728,574)
- EVP, CLO, CORP. SEC. acquired 28,092 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nouri Alaleh EVP, CLO, CORP. SEC. | 2024-12-04 | Option exercise 10b5-1 | +11,838 | $7.27 | $86,062 | 64,310 | D |
| Nouri Alaleh EVP, CLO, CORP. SEC. | 2024-12-04 | Option exercise 10b5-1 | +4,162 | $34.99 | $145,628 | 68,472 | D |
| Nouri Alaleh EVP, CLO, CORP. SEC. | 2024-12-04 | Option exercise 10b5-1 | +12,092 | $37.02 | $447,646 | 80,564 | D |
| Nouri Alaleh EVP, CLO, CORP. SEC. | 2024-12-04 | Sale 10b5-1 | −3,787 | $96.12 | $364,006 | 76,777 | D |
| Nouri Alaleh EVP, CLO, CORP. SEC. | 2024-12-04 | Sale 10b5-1 | −16,187 | $96.98 | $1,569,815 | 60,590 | D |
| Nouri Alaleh EVP, CLO, CORP. SEC. | 2024-12-04 | Sale 10b5-1 | −8,118 | $97.90 | $794,752 | 52,472 | D |
| Derivatives | |||||||
| Nouri Alaleh EVP, CLO, CORP. SEC. | 2024-12-04 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,838 | 21,056 | D | ||
| Nouri Alaleh EVP, CLO, CORP. SEC. | 2024-12-04 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,162 | 2,728 | D | ||
| Nouri Alaleh EVP, CLO, CORP. SEC. | 2024-12-04 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,092 | 26,094 | D | ||
| Open-market sales · 28,092 sh · avg $97.13 · $2,728,574 | |||||||
Loading xslF345X05/wk-form4_1733519866.xml…